
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Genome & Company is a global biopharmaceutical company that focuses on developing microbiome pharmaceuticals, consumer products and novel immune checkpoint inhibitors based on real-world clinical data and Multi-Omics analytic technology. Since its establishment in 2015, as a global leader in the field of microbiome for immuno-oncology and novel drug discovery for immuno-oncology target, Genome & Company has been collaborating with global pharmaceutical companies, research institutions and hospitals in Korea based on the Bed-to-Bench approach (real-world clinical data driven R&D strategy) of GNOCLETM, a platform for discovering novel drug candidates. Genome & Co strives to accelerate the development of innovative medicine...
Microbiome,immune checkpoint inhibitors,immuno-oncology,research and development,genome and company,마이크로바이옴,면역항함제,맞춤형면역항암제,지놈앤컴퍼니,항체개발,임상개발,and 신규타깃 면역항암제
Genome & company operates in the Biotechnology research industry.
Genome & company's revenue is 11m - 100m
Genome & company has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.